参考文献

  • World Health Organization. ICD-11: Clinical descriptions and diagnostic requirements – Mental, behavioural and neurodevelopmental disorders. 2024. WHO
  • NICE. NG87: Attention deficit hyperactivity disorder: diagnosis and management. Last reviewed: 7 May 2025. NICE
  • American Psychiatric Association. What is ADHD?. psychiatry.org
  • CDC. Symptoms of ADHD. Updated: May 16, 2024. CDC
  • CDC. Diagnosing ADHD. Updated: Oct 3, 2024. CDC
  • CDC. Treatment of ADHD. Updated: May 16, 2024. CDC
  • CDC. ADHD in the Classroom: Helping Children Succeed in School. Updated: Oct 22, 2024. CDC
  • NIMH (U.S.). Attention-Deficit/Hyperactivity Disorder (ADHD). nimh.nih.gov
  • American Academy of Pediatrics (AAP). Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents. Pediatrics. 2019. AAP Publications
  • American Academy of Neurology (AAN). Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis. 2016. aan.com
  • NCBI Bookshelf / SAMHSA. DSM-IV to DSM-5 Changes – Table 7: ADHD presentations. NCBI
  • APA. DSM-5 Fact Sheet: Attention-Deficit/Hyperactivity Disorder (ADHD). psychiatry.org
  • ASRS v1.1関連

  • Harvard Medical School / National Comorbidity Survey. ASRS v1.1 – Official portal. Harvard Medical School
  • Harvard Medical School. ASRS v1.1 6-Question Screener – English. Harvard Medical School
  • Harvard Medical School. ASRS v1.1 6-Question Screener – 日本語版. Harvard Medical School
  • Harvard Medical School. ASRS v1.1 18-item Symptom Checklist – 日本語版. Harvard Medical School
  • Kessler RC, et al. The WHO Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine. 2005. PubMed
  • Adler LA, et al. Validity of pilot Adult ADHD Self-Report Scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry. 2006. PubMed
  • Kessler RC, et al. Validity of the WHO ASRS Screener in health plan members. Int J Methods Psychiatr Res. 2007. PubMed
  • Takeda T, et al. Psychometric properties of the Japanese version of the ASRS (ASRS-J). Research in Developmental Disabilities. 2017. ScienceDirect
  • 病態・神経生物学・総説・大規模研究

  • Rubia K. Cognitive Neuroscience of ADHD and its Clinical Translation. Frontiers in Human Neuroscience. 2018. PMC
  • ENIGMA-ADHD (Hoogman M, et al.). Subcortical brain volume differences in ADHD: mega-analysis. Lancet Psychiatry. 2017. PMC
  • ENIGMA-ADHD (Hoogman M, et al.). Brain Imaging of the Cortex in ADHD: A Coordinated Analysis. Am J Psychiatry. 2019. PsychiatryOnline
  • Faraone SV, et al. World Federation of ADHD International Consensus Statement: 208 Evidence-based Conclusions about ADHD. Neurosci Biobehav Rev. 2021. PMC
  • 薬物療法・心理社会的介入

  • Cortese S, et al. Comparative efficacy and tolerability of medications for ADHD across age groups: network meta-analysis. Lancet Psychiatry. 2018. PubMed
  • Ostinelli EG, et al. ADHD treatments for adults: systematic review & component network meta-analysis. Lancet Psychiatry. 2025. ランセット
  • Cochrane Review. Cognitive-behavioural interventions for adults with ADHD. 2018. PMC
  • 日本の公的情報

  • 国立精神・神経医療研究センター. ADHD(注意欠如・多動症). 国立精神・神経医療研究センター
  • 国立特別支援教育総合研究所. 注意欠陥多動性障害(ADHD)のある子どもの指導・支援. cpedd.nise.go.jp
  • 厚生労働省. 発達障害の理解 ~メンタルヘルスに配慮すべき人への支援~. 厚生労働省
  • 教育的配慮

  • U.S. Department of Education, Office for Civil Rights. Dear Colleague Letter & Resource Guide on Students with ADHD (Section 504). 2016. U.S. Department of Education